New research suggests the HPV vaccine is preventing cancer in men, as well as in women, but fewer boys than girls are getting the shots in the United States. Primary Menu Sections.

New research shows that the HPV vaccine dramatically reduces the risk of head and neck cancers, especially in boys and men. Both girls and boys should get the HPV vaccine at age 11 or 12, though ...

Please use one of the following formats to cite this article in your essay, paper or report: APA. ACROBiosystems. (2025, January 24). Combating cervical cancer with HPV vaccine research.

An official from the Gates Foundation, which funded the research, said that if the HPV vaccine were a single dose, twice as many people could get protection in an ideal situation.

The vaccine may still provide some benefit for people over age 26, and is approved up until age 45. The C.D.C. says that people between the ages of 27 and 45 might get the vaccine after talking to ...

The HPV vaccine has the most misinformation of any vaccine, research suggests. “We know that it affects health behavior,” Boatman, who studied HPV vaccine misinformation across Facebook ...

By CARLA K. JOHNSON (AP Medical Writer) New research suggests the HPV vaccine is preventing cancer in men, as well as in women, but fewer boys than girls are getting the shots in the United States.

An official from the Gates Foundation, which funded the research, said that if the HPV vaccine were a single dose, twice as many people could get protection in an ideal situation.

By CARLA K. JOHNSON (AP Medical Writer) New research suggests the HPV vaccine is preventing cancer in men, as well as in women, but fewer boys than girls are getting the shots in the United States.

In the U.S., the HPV vaccine has been recommended since 2006 for girls at age 11 or 12, and since 2011 for boys the same age. Catch-up shots are recommended for anyone through age 26 who hasn’t ...

FILE - A doctor holds a vial of the human papillomavirus (HPV) vaccine Gardasil in Chicago on Aug. 28, 2006. Research published Thursday, May 23, 2024, by the American Society of Clinical Oncology ...